Advertisement
Screener

MPM ASSET MANAGEMENT LLC Historic Quarter Change: USA Stocks, Reduced

MPM ASSET MANAGEMENT LLC historic quarter change: USA Stocks, Reduced

In share positions in stocks (listed in the US), over 20 quarters from 2013-06-30 to 2025-09-30, MPM ASSET MANAGEMENT LLC opened 2 positions, added to 1, reduced 9 and sold out of 3.

  • Q1 2025: Stock RPTX; Country of operation —; Class Common; Shares before 1,683,707.
  • Q4 2024: Stock RPTX; Country of operation —; Class Common; Shares before 2,242,636.
  • Q4 2024: Stock TRDA; Country of operation United States; Class Common; Shares before 4,425,784.
  • Q3 2024: Stock DYN; Country of operation United States; Class Common; Shares before 1,561,496.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1263048), 20 quarters: Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-13); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-08); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-11); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-04); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-12); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-07-29); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-04-27); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-02); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-10-23); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-07-17); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-08); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-01-23); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-26). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2008-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q1 2025RPTX
Repare Therapeutics, Inc.
Common1,683,7071,121,318-562,389$2,205,656$1,105,620-$1,100,0362025-05-15
Q4 2024RPTX
Repare Therapeutics, Inc.
Common2,242,6361,683,707-558,929$7,714,668$2,205,656-$5,509,0122025-02-14
Q4 2024TRDA
Entrada Therapeutics, Inc.
United StatesCommon4,425,7844,381,062-44,722$70,724,028$75,748,562+$5,024,5342025-02-14
Q3 2024DYN
Dyne Therapeutics, Inc.
United StatesCommon1,561,496682,376-879,120$55,105,194$24,510,946-$30,594,2482024-11-13
Q2 2024DYN
Dyne Therapeutics, Inc.
United StatesCommon3,451,3031,561,496-1,889,807$97,982,492$55,105,194-$42,877,2982024-08-14
Q1 2024DYN
Dyne Therapeutics, Inc.
United StatesCommon4,951,3033,451,303-1,500,000$65,852,330$97,982,492+$32,130,1622024-05-15
Q2 2014MGNX
MacroGenics, Inc.
United StatesCommon1,780,9553,168-1,777,787$49,564,000$69,000-$49,495,0002014-07-17
Q1 2014PCRX
Pacira Pharmaceuticals, Inc.
United StatesCommon100,00039,025-60,975$5,749,000$2,731,000-$3,018,0002014-05-08
Q4 2013PCRX
Pacira Pharmaceuticals, Inc.
United StatesCommon824,255100,000-724,255$39,630,000$5,749,000-$33,881,0002014-01-23

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet